Medicinal Chemistry Planning Laboratory, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife-PE, Brazil.
Department of Virology and of Experimental Therapeutics, Aggeu Magalhães Institute, Oswaldo Cruz Foundation (Fiocruz), Recife-PE, Brazil.
Mini Rev Med Chem. 2019;19(1):56-62. doi: 10.2174/1389557518666180424093305.
Arboviruses have been spreading rapidly throughout the Western Hemisphere in recent decades. Among the arboviruses with high morbidity and mortality are the members of the Alphavirus and Flavivirus genera. Within the first genus, Chikungunya Virus (CHIKV) is considered one of the most challenging human arboviral infection worldwide, against which there is no specific antivirals. Flaviviruses are some of the main viruses responsible for encephalitis, haemorrhagic disease and developmental defects. Dengue virus (DENV), Japanese Encephalitis Virus (JEV), West Nile Virus (WNV) and Zika Virus (ZIKV) are examples of flaviviruses without clinically approved antiviral agents. Thus, the search for new antivirals becomes highly important. One of the strategies that can be employed to obtain new drugs is the identification and utilization of privileged structures. Isatin is an example of a privileged molecular framework, displaying a broad spectrum of biological activities, including antiviral action. Obtaining and studying the antiviral properties of isatin derivatives have helped to identify important agents with potential activity against different arboviruses. This article reviews some of these isatin derivatives, their structures and antiviral properties reported against this important group of viruses.
虫媒病毒在近几十年中在西半球迅速传播。在具有高发病率和死亡率的虫媒病毒中,包括甲病毒属和黄病毒属的成员。在第一个属中,基孔肯雅病毒(CHIKV)被认为是全球最具挑战性的人类虫媒病毒感染之一,目前尚无针对该病毒的特效抗病毒药物。黄病毒是引起脑炎、出血性疾病和发育缺陷的主要病毒之一。登革热病毒(DENV)、日本脑炎病毒(JEV)、西尼罗河病毒(WNV)和寨卡病毒(ZIKV)是没有临床批准的抗病毒药物的黄病毒的例子。因此,寻找新的抗病毒药物变得非常重要。获得新药的一种策略是识别和利用特权结构。色氨酸是一种特权分子框架的例子,显示出广泛的生物活性,包括抗病毒作用。获得和研究色氨酸衍生物的抗病毒特性有助于鉴定出对不同虫媒病毒具有潜在活性的重要药物。本文综述了一些色氨酸衍生物,它们的结构和针对这组重要病毒的抗病毒特性。